Related references
Note: Only part of the references are listed.The risk of obstetrical syndromes after solid organ transplantation
Ivo Brosens et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2014)
Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation
Troels K. Bergmann et al.
CLINICAL PHARMACOKINETICS (2012)
Differences in expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender
V. Mericq et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: Fact or fiction?
Stefanie Lam et al.
ANNALS OF PHARMACOTHERAPY (2008)
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: A University of Washington specialized center of research study
M. F. Hebert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacokinetics of corticosteroids during pregnancy
Luis D. Pacheco et al.
AMERICAN JOURNAL OF PERINATOLOGY (2007)
Anti-inflammatory and immunosuppressive drugs and reproduction
Monika Ostensen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome
PJV Heimel et al.
PLACENTA (2005)
Dose adjustment in patients with liver disease
F Delco et al.
DRUG SAFETY (2005)
Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development
HJL Speirs et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Prescription drug use in pregnancy
Susan E. Andrade et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study
C Gur et al.
REPRODUCTIVE TOXICOLOGY (2004)
Structural determinants of P-glycoprotein-mediated transport of glucocorticoids
CR Yates et al.
PHARMACEUTICAL RESEARCH (2003)
11β-hydroxysteroid dehydrogenase types 1 and 2:: An important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids
S Diederich et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Course of placental 11β-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation
E Schoof et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Share Paper
